Post by AbbVie

2,064,321 followers

NEWS: The European Commission has granted marketing authorization of our medicine as part of a combination regimen for adult patients with relapsed/refractory (R/R) follicular #lymphoma (FL), developed in collaboration with Genmab. Learn more: https://bit.ly/4vO7Dfx [Video description: On-screen text reads, “Oncology News”]

Post content

Video Content